BHCM
Brevan Howard Capital Management Portfolio holdings
AUM
$9.09B
1-Year Return
13.74%
This Quarter Return
+1.15%
1 Year Return
+13.74%
3 Year Return
+18.18%
5 Year Return
–
10 Year Return
–
AUM
$1.1B
AUM Growth
+$106M
(+11%)
Cap. Flow
+$14.9M
Cap. Flow
% of AUM
1.35%
Top 10 Holdings %
Top 10 Hldgs %
18.37%
Holding
1,387
New
406
Increased
260
Reduced
240
Closed
449
Top Buys
| 1 |
Workday
WDAY
|
+$30.6M |
| 2 |
CME Group
CME
|
+$22.1M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$21.9M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$19M |
| 5 |
KKR & Co
KKR
|
+$18M |
Top Sells
| 1 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$111M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$38.7M |
| 3 |
Home Depot
HD
|
+$15.6M |
| 4 |
NVIDIA
NVDA
|
+$12.3M |
| 5 |
SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$11.5M |
Sector Composition
| 1 | Technology | 22.1% |
| 2 | Financials | 15% |
| 3 | Industrials | 13.15% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Energy | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HPP
851
Hudson Pacific Properties
HPP
$1.12B
| $91.9K | ﹤0.01% |
+14,246
| New | +$91.9K |
|
852
Lyra Therapeutics
LYRA
$10.4M
| $87.3K | ﹤0.01% |
+281
| New | +$87.3K |
|
853
Lunai Bioworks Inc. Common Stock
RENB
$46.3M
| $86.5K | ﹤0.01% |
+32,652
| New | +$86.5K |
|
854
Cricut
CRCT
$1.38B
| $86.1K | ﹤0.01% |
+18,090
| New | +$86.1K |
|
|
SYRS
855
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $85.8K | ﹤0.01% |
+16,036
| New | +$85.8K |
|
856
Navitas Semiconductor
NVTS
$1.3B
| $84.6K | ﹤0.01% |
17,737
+6,607
| +59% | +$31.5K |
|
857
Atea Pharmaceuticals
AVIR
$262M
| $84.1K | ﹤0.01% |
20,809
-4,908
| -19% | -$19.8K |
|
858
Scilex Holding
SCLX
$176M
| $83.9K | ﹤0.01% |
+1,508
| New | +$83.9K |
|
859
Medallion Financial
MFIN
$248M
| $82.2K | ﹤0.01% |
+10,393
| New | +$82.2K |
|
860
Mama's Creations
MAMA
$389M
| $79.8K | ﹤0.01% |
+15,968
| New | +$79.8K |
|
861
Intuitive Machines
LUNR
$1B
| $78.4K | ﹤0.01% |
+12,547
| New | +$78.4K |
|
862
Amneal Pharmaceuticals
AMRX
$3.17B
| $77.7K | ﹤0.01% |
12,817
-35,887
| -74% | -$217K |
|
|
NXDR
863
Nextdoor Holdings
NXDR
$794M
| $76.7K | ﹤0.01% |
34,101
+891
| +3% | +$2.01K |
|
864
Lantronix
LTRX
$179M
| $76.6K | ﹤0.01% |
+21,525
| New | +$76.6K |
|
865
E.W. Scripps
SSP
$257M
| $76.6K | ﹤0.01% |
+19,483
| New | +$76.6K |
|
866
Aquestive Therapeutics
AQST
$599M
| $76.5K | ﹤0.01% |
+17,965
| New | +$76.5K |
|
867
Vanda Pharmaceuticals
VNDA
$272M
| $75.2K | ﹤0.01% |
18,288
-7,383
| -29% | -$30.3K |
|
868
Custom Truck One Source
CTOS
$1.33B
| $74.5K | ﹤0.01% |
12,793
+1,011
| +9% | +$5.88K |
|
|
CBIO
869
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
| $70K | ﹤0.01% |
+233
| New | +$70K |
|
870
Relmada Therapeutics
RLMD
$50.5M
| $69.4K | ﹤0.01% |
+14,918
| New | +$69.4K |
|
871
CureVac
CVAC
$1.21B
| $68.9K | ﹤0.01% |
22,738
+8,633
| +61% | +$26.2K |
|
872
Yext
YEXT
$1.07B
| $68.3K | ﹤0.01% |
11,321
-10,220
| -47% | -$61.6K |
|
873
Open Lending Corp
LPRO
$260M
| $66.7K | ﹤0.01% |
10,650
-12,101
| -53% | -$75.8K |
|
874
Brookdale Senior Living
BKD
$1.77B
| $66.6K | ﹤0.01% |
10,070
-12,953
| -56% | -$85.6K |
|
|
CNSL
875
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $64.4K | ﹤0.01% |
+14,914
| New | +$64.4K |
|